Hemophilia A or B Clinical Trial
Official title:
A MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF SUBCUTANEOUS PF-06741086 IN SUBJECTS WITH SEVERE HEMOPHILIA
This study is designed to evaluate the safety, tolerability and efficacy of long-term treatment with PF-06741086 in subjects with severe hemophilia who participated in the 3-month Phase 1b/2 B7841002 study. Additionally, de novo subjects will be recruited into this study.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02974855 -
PF-06741086 Multiple Dose Study in Severe Hemophilia
|
Phase 2 |